![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Wednesday, July 02, 2014 12:25:10 PM
Recent ANIP News
- Form 8-K - Current report • Edgar (US Regulatory) • 02/05/2025 12:00:31 PM
- ANI Pharmaceuticals to Present at the Guggenheim Biotech Conference • GlobeNewswire Inc. • 01/28/2025 09:30:00 PM
- Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors • Edgar (US Regulatory) • 01/21/2025 09:04:25 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/13/2025 09:15:15 PM
- Alcami Announces CEO Transition • PR Newswire (US) • 01/13/2025 04:12:00 PM
- ANI Pharmaceuticals Provides Preliminary Fourth Quarter and 2024 Financial Results and Preliminary 2025 Outlook • GlobeNewswire Inc. • 01/13/2025 11:50:00 AM
- ANI Pharmaceuticals Announces the FDA Approval and Launch of Prucalopride Tablets with 180-Day CGT Exclusivity • GlobeNewswire Inc. • 01/02/2025 11:50:00 AM
- ANI Pharmaceuticals to Present at the 43rd Annual J.P. Morgan Healthcare Conference • GlobeNewswire Inc. • 12/30/2024 09:05:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/18/2024 10:59:06 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 12/17/2024 10:35:23 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/16/2024 09:20:29 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/12/2024 10:08:37 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/27/2024 10:38:49 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 11/27/2024 12:44:03 AM
- ANI Pharmaceuticals to Present at 36th Annual Piper Sandler Healthcare Conference • GlobeNewswire Inc. • 11/26/2024 09:30:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/20/2024 12:00:30 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/18/2024 09:05:16 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/18/2024 09:03:26 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/14/2024 09:16:19 PM
- Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend] • Edgar (US Regulatory) • 11/13/2024 09:30:24 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/08/2024 01:01:37 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/08/2024 11:55:35 AM
- ANI Pharmaceuticals Reports Record Third Quarter 2024 Financial Results and Raises 2024 Guidance • GlobeNewswire Inc. • 11/08/2024 11:50:28 AM
- ANI Pharmaceuticals to Present at Guggenheim's Inaugural Healthcare Innovation Conference and Jefferies London Healthcare Conference in November • GlobeNewswire Inc. • 11/04/2024 09:30:00 PM
- ANI Pharmaceuticals to Discuss Third Quarter 2024 Financial Results on November 8, 2024, at 8:00 a.m. ET • GlobeNewswire Inc. • 10/30/2024 09:00:00 PM
UAV Corp. Expanding in the Global UAV Market, Projected to Exceed $58 Billion by 2027, with Increasing Government and Commercial Sector Adoption • UMAV • Feb 6, 2025 8:30 AM
VAYK Project $700K 2024 Revenue with $150K Net Profit • VAYK • Feb 5, 2025 12:43 PM
UAV Corp (UMAV) Kicks Off Landmark "SKY" Hangar Project with Land Clearing at Costin Airport Setting Stage for Q1 2025 Groundbreaking • UMAV • Feb 5, 2025 8:30 AM
HealthLynked Corp. Releases Annual Shareholder Letter Highlighting Recent Product Development and Strategic Vision for the Future • HLYK • Feb 4, 2025 8:00 AM
Wytec Wins Multi-State Government Contract for AI Gunshot Detection • WYTC • Feb 3, 2025 7:16 AM
UAV Corp. Retains Legal Counsel to Address Legacy Debt from HTTI Era; 500 Million Authorized Shares Confirmed - UAV Corp. Delivers on Strategic Commitments • UMAV • Jan 31, 2025 1:30 PM